Can you provide the last earnings date for ADC THERAPEUTICS SA?
ADC THERAPEUTICS SA (ADCT) last reported earnings on 3/10/2026.
ADC THERAPEUTICS SA (ADCT) Earnings History & Surprises
NYSE:ADCT • CH0499880968
Current stock price
4.11 USD
-0.14 (-3.29%)
At close:
4.11 USD
0 (0%)
After Hours:
ADCT Earnings overview
Past quarterly earnings results for ADC THERAPEUTICS SA (ADCT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.22
- Revenue Estimate
- 19.944M
Last Reported
Most Recent- Release Date
- Mar 10, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.04
- EPS Surprise
- 85.39%
- Revenue Surprise
- 5.68%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.04 | -0.27 | 85.39% | 86.21% | 23.058M | 21.818M | 5.68% | 36.36% |
| Q3 2025 | -0.30 | -0.37 | 18.68% | 28.57% | 16.427M | 17.419M | -5.69% | -11.03% |
| Q2 2025 | -0.38 | -0.48 | 21.40% | - | 18.839M | 18.218M | 3.41% | 8.21% |
| Q1 2025 | -0.36 | -0.41 | 12.49% | 35.71% | 23.033M | 18.063M | 27.51% | 27.59% |
| Q4 2024 | -0.29 | -0.42 | 30.94% | 71.84% | 16.91M | 19.387M | -12.78% | 0.71% |
| Q3 2024 | -0.42 | -0.40 | -4.24% | 27.59% | 18.464M | 18.831M | -1.95% | 27.40% |
| Q2 2024 | -0.38 | -0.47 | 18.56% | 34.48% | 17.41M | 19.174M | -9.20% | -9.71% |
| Q1 2024 | -0.56 | -0.57 | 1.20% | 24.32% | 18.053M | 18.464M | -2.23% | -4.94% |
| Q4 2023 | -1.03 | -0.51 | -100.76% | -243.33% | 16.79M | 15.633M | 7.40% | -75.95% |
| Q3 2023 | -0.58 | -0.65 | 10.34% | 10.77% | 14.493M | 15.461M | -6.26% | -81.01% |
| Q2 2023 | -0.58 | -0.47 | -24.39% | 30.95% | 19.283M | 42.386M | -54.51% | 11.53% |
| Q1 2023 | -0.74 | -0.68 | -8.28% | -236.36% | 18.992M | 20.49M | -7.31% | -59.16% |
| Q4 2022 | -0.30 | -0.29 | -2.55% | 33.33% | 69.8M | 66.798M | 4.49% | 310.35% |
| Q3 2022 | -0.65 | -0.36 | -80.60% | 30.11% | 76.32M | 47.947M | 59.18% | 480.38% |
| Q2 2022 | -0.84 | -0.93 | 9.90% | 12.50% | 17.29M | 20.925M | -17.37% | 359.84% |
| Q1 2022 | -0.22 | -0.71 | 69.00% | 52.17% | 46.5M | 29.516M | 57.54% | - |
| Q4 2021 | -0.45 | -0.87 | 48.53% | 57.14% | 17.01M | 16.787M | 1.33% | - |
| Q3 2021 | -0.93 | -0.94 | 0.59% | -20.78% | 13.15M | 7.534M | 74.54% | - |
| Q2 2021 | -0.96 | -0.88 | -9.44% | -31.51% | 3.76M | 2.27M | 65.64% | - |
| Q1 2021 | -0.46 | -0.92 | 50.17% | 32.35% | 96.217K | -100.00% | - | |
| Q4 2020 | -1.05 | -0.39 | -168.54% | - | 875.16K | -100.00% | - | |
| Q3 2020 | -0.77 | -0.83 | 6.80% | - | 43.523K | -100.00% | - | |
| Q2 2020 | -0.73 | -0.66 | -10.11% | - | 305.49K | -100.00% | - | |
| Q1 2020 | -0.68 | - | - | 298.35K | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
34.49%
Max EPS beat (4)
85.39%
Min EPS beat (4)
12.49%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
7.73%
Max Revenue beat (4)
27.51%
Min Revenue beat (4)
-5.69%
Analysis
In the last 4 quarters, ADCT has consistently beaten EPS estimates in all releases
ADCT has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, ADCT has beaten the EPS estimates by 34.5% on average.
In the last 4 quarters, ADCT has beaten the revenue estimates by 7.7% on average.
Related analysis
ADC THERAPEUTICS SA / ADCT Earnings FAQ
Can you provide information on whether ADC THERAPEUTICS SA beat earnings estimates in the last quarter?
ADC THERAPEUTICS SA (ADCT) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does ADCT stock beat earnings estimates?
In the last 4 quarters, ADC THERAPEUTICS SA (ADCT) has beaten EPS estimates in 4 out of 4 releases.